Volatile Coronavirus Stock Plays-Rayno BioBeat- Update April 7…GNMK an after hours mover

Update 4/7...Genmark Dx (GNMK)  up 22% after hours on revised revenue guidance for 2020: Total revenues of $38.7M expected. Biotechs mainly in the red and big sell-off in plays below; other notable movers: VIR off 12.56%, CODX off 11.8%, MRNA off 7.56%. Gilead Sciences (GILD) was off 3.94% maybe because a Baird analyst Brian Skorney came on CNBC with skepticism about the efficacy of remdesivir for coronavirus but speaking without new clinical data. Update 4/6... On a Huge Rally Day with the...

read more

Biotech Movers on a Roller Coaster Week as Coronavirus Speculation Ramps Up…Update-9 on March 30…major rally

3/30 11;30a Major news on COVID-19 diagnostics spark rally. Abbott launches 5 minute test. ABT up 7.28% ,JNJ up 6.8%, all large caps up, IBB up 2.55, XBI up 1.61%. Risk reward still looks good for biotech by year-end 2020. See IBB 2 yr chart below. ======== 3/27 After today's big drop in the market in the final hour the only real metric that tracks the market appears to be new cases of coronavirus infections. US cases rose over 100k according to John Hopkins.The NASDAQ fell 3.79% on Friday....

read more

Innovation Drives Biotech Stocks-Time to Nibble for Longer Term…Update-1 rally time

Update-1 nice broad biotech rally on stimulus hopes with biotech now seen as possible solution https://www.barrons.com/articles/the-dow-is-up-900-points-after-congress-agrees-on-8-3-billion-package-to-battle-coronavirus-51583350527?mod=hp_LATEST XBI up over 3%to $93 handle . IBB up over 3% o $129 handle; Roche (RHHBY) up over 3.5%. DX and tools running along with microcaps; TMO deal for QGEN helps MO. ======= Innovation Drives Biotech Stocks Biotech Stocks Catch Bids-Is it time to nibble on...

read more

Pin It on Pinterest